MétaCan
Menu
Back to cohort
Record W3088110723 · doi:10.1016/j.ymthe.2020.09.019

Gene Therapy for Hemophilia: Are Expectations Matching Reality?

2020· letter· en· W3088110723 on OpenAlexaff
Glenn F. Pierce

Bibliographic record

VenueMolecular Therapy · 2020
Typeletter
Languageen
FieldMedicine
TopicHemophilia Treatment and Research
Canadian institutionsCanadian Hemophilia Society
Fundersnot available
KeywordsGenetic enhancementMatching (statistics)MedicineGeneBiologyGeneticsPathology

Abstract

fetched live from OpenAlex

BioMarin Pharmaceuticals’ ongoing phase 3 trial (ClinicalTrials.gov: NCT03370913) is designed to test a single dose (6E13 vg/kg) of valoctocogene roxaparvovec (an adeno-associated viral serotype 5 vector expressing B-domain deleted coagulation factor VIII [AAV5-FVIII]) in men with severe hemophilia A. In 2019, BioMarin reached an agreement with the US Food and Drug Administration (FDA), as part of the breakthrough therapy designation, that they could submit data for provisional approval on 16/134 participants at 6 months, rather than the full study results at the 1 year mark.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.093
metaresearch head score (Gemma)0.253
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.093
Threshold uncertainty score0.493

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0930.253
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0010.001
Science and technology studies0.0030.011
Scholarly communication0.0150.020
Open science0.0030.005
Research integrity0.0090.025
Insufficient payload (model declined to judge)0.0160.007

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.061
GPT teacher head0.340
Teacher spread0.280 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueMolecular TherapySame topicHemophilia Treatment and ResearchFrench-language works237,207